M.D.
Hematologist-Oncologist
2006, M.D., Jordan University of Science and Technology, Irbid, Jordan
2010-2013, University of Southern California, Los Angeles, CA
2007-2010, Internal Medicine at Creighton University, Omaha, NE
2020-present, Associate Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
2014-2020, Assistant Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
2014, BMT Fellow, City of Hope, Duarte, CA
2013, Clinical Instructor, Hematology and Bone Marrow Transplantation Department, University of Southern California, Los Angeles, CA
2012-2013, Chief of Hematology Fellows, University of Southern California, Los Angeles, CA
Ibrahim T. Aldoss, M.D., is hematologist-oncologist at City of Hope® Cancer Center Duarte. A renowned blood cancer expert, Dr. Aldoss specializes in diagnosing and treating disorders including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Board-certified in internal medicine, hematology and oncology, Dr. Aldoss combines a compassionate approach to care with a groundbreaking research agenda that aims to transform leukemia treatment.
Dr. Aldoss holds several leadership roles in the field of leukemia research, including serving as co-director of the Hematology Tissue Bank and the Leukemia Registry. His work focuses on optimizing outcomes for younger adults with ALL, developing more effective immunotherapies and identifying new treatment targets for harder-to-treat diagnoses. He also leads clinical trials investigating promising therapies for patients with acute leukemias.
Originally from Jordan, Dr. Aldoss earned his medical degree at the Jordan University of Science and Technology, then went on to complete his internal medicine training at Creighton University in Omaha, Nebraska, and a fellowship in hematology-oncology at the Keck School of Medicine of USC in Los Angeles. He joined City of Hope in 2014, where he specializes in bone marrow transplants and advanced leukemia treatment and research. Dr. Aldoss has published over 100 peer-reviewed articles and regularly presents his research at conferences around the world.